+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

Carimune Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Carimune Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Cytogam (Cytomegalovirus Immune Globulin Intravenous) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Cytogam (Cytomegalovirus Immune Globulin Intravenous) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 182 Pages
  • Global
From
HIV Attachment Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Attachment Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fusion Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Integrase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Integrase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Exportin-1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Exportin-1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 185 Pages
  • Global
From
Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 59 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • December 2024
  • Global
From
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • September 2024
  • 112 Pages
  • Global
From
Zidovudine (CAS 30516-87-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Zidovudine (CAS 30516-87-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • April 2025
  • 50 Pages
  • Global
From
Stavudine (CAS 3056-17-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Stavudine (CAS 3056-17-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • April 2025
  • 50 Pages
  • Global
From
Indinavir (CAS 150378-17-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Indinavir (CAS 150378-17-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more